Dergiler / İstanbul Kuzey Klinikleri / 2020 / Cilt: 7 - Sayı: 2

Telecardiographic measurements for device migration: A useful tool for follow-up

Sayfa
106–111
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

During the first year of follow-up, changes in angle measurements on postoperative$1^{st},;3^{rd},;6^{th},;and;12^{th}$ month telecardiograms were compared against the incidence of device thrombus and serum LactateDehydrogenase (LDH) levels.RESULTS: Patients who were diagnosed with device thrombosis had more change in inflow cannula angles than patientswithout device thrombus (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: Pump thrombosis in left ventricular assist device (LVAD) patients is an important cause of mortality and morbidity.
📊
Temel Bulgular & Veri:In this study, we aimed to evaluate the migration of the inflow cannulas in patients withLVADs using angle measurements on telecardiogramsMETHODS: Twenty-three patients who were implanted left ventricular assist devices in our clinic between February 2013 andApril 2016 were included in our study.
💡
Sonuç & Katkı:During the first year of follow-up, changes in angle measurements on postoperative$1^{st},;3^{rd},;6^{th},;and;12^{th}$ month telecardiograms were compared against the incidence of device thrombus and serum LactateDehydrogenase (LDH) levels.RESULTS: Patients who were diagnosed with device thrombosis had more change in inflow cannula angles than patientswithout device thrombus (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2013 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVE: Pump thrombosis in left ventricular assist device (LVAD) patients is an important cause of mortality and morbidity. Inflow cannula migration is a predisposing factor for pump thrombosis. Telecardiographic measurements can be usedto follow up apical cannula deviation. In this study, we aimed to evaluate the migration of the inflow cannulas in patients withLVADs using angle measurements on telecardiogramsMETHODS: Twenty-three patients who were implanted left ventricular assist devices in our clinic between February 2013 andApril 2016 were included in our study. During the first year of follow-up, changes in angle measurements on postoperative$1^{st},;3^{rd},;6^{th},;and;12^{th}$ month telecardiograms were compared against the incidence of device thrombus and serum LactateDehydrogenase (LDH) levels.RESULTS: Patients who were diagnosed with device thrombosis had more change in inflow cannula angles than patientswithout device thrombus (p

🔖

Bu Makaleye Atıf Yap

BAYRAKTAR, F. A., METE, M. T., SARGIN, M., ERDOĞAN, S. B., BAŞTOPÇU, M., YILDIRIMTÜRK, Ö., ORHAN, G., AKA, S. A. (2022). Telecardiographic measurements for device migration: A useful tool for follow-up. İstanbul Kuzey Klinikleri, Cilt: 7 - Sayı: 2, 106–111. https://ajindex.com/articles/551368

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011;57:1890–8
  2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435–43
  3. Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014;370:33–40
  4. Boyle AJ, Russell SD, Teuteberg JJ, Slaughter MS, Moazami N, Pagani FD, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anticoagulation. J Heart Lung Transplant 2009;28:881–7
  5. John R, Kamdar F, Liao K, Colvin-Adams M, Miller L, Joyce L, et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg 2008;136:1318–23
  6. Adamson RM, Mangi AA, Kormos RL, Farrar DJ, Dembitsky WP. Principles of HeartMate II implantation to avoid pump malposition and migration. J Card Surg 2015;30:296–9
  7. Taghavi S, Ward C, Jayarajan SN, Gaughan J, Wilson LM, Mangi AA. Surgical technique influences HeartMate II left ventricular assist device thrombosis. Ann Thorac Surg 2013;96:1259–65
  8. Sorensen EN, Hiivala NJ, Jeudy J, Rajagopal K, Griffith BP. Computed tomography correlates of inflow cannula malposition in a continuousflow ventricular-assist device. J Heart Lung Transplant 2013;32:654– 57
  9. Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, et al; HeartMate LVAS Investigators. Left Ventricular Assist System. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122:1186–95
  10. Rose EA, Levin HR, Oz MC, Frazier OH, Macmanus Q, Burton NA, et al. Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation 1994;90:II87–91
  11. Han JJ, Gaffey AC, Sooppan R, Hung G, Venkat